Connection

Patrick Mallon to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Patrick Mallon has written about Antibodies, Monoclonal, Humanized.
Patrick Mallon
Connection Strength
0.376
Antibodies, Monoclonal, Humanized
  1. Tocilizumab for the treatment of non-critical COVID-19 pneumonia: an overview of the rationale and clinical evidence to date. Expert Rev Clin Pharmacol. 2021 Oct; 14(10):1279-1287.
    View in: PubMed
    Score: 0.194
  2. The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Sep 03; 21(1):758.
    View in: PubMed
    Score: 0.182
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.